Predictors for cancer treatment
The present invention provides methods of predicting a response to a cancer treatment by determining CD68 level or PSMB1 (P11A) polymorphism in a biological sample and the presence or quantity of a second biomarker in the patient. The invention also provides kits and methods for treating cancer.
Janssen Pharmaceutica NV
G A A A A A C A A G A G
G01N A61K A61P A61K A61K A61K C12Q A61K A61P G01N A61K G01N
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional
Erin DeVay Weimin Deborah
Henitz Li Ricci